An important finding of this study is that fibroblasts activation can be inhibited by targeting S100A4 through downregulating STAT3 phosphorylation (Figures 4B, C), providing us a novel potential therapeutic strategies of IPF. This evidence concerns the gene S100A4 and idiopathic pulmonary fibrosis.